Department of Urology, Mayo Clinic College of Medicine, 200 1st St SW, Rochester, MN, USA.
Curr Urol Rep. 2013 Apr;14(2):130-7. doi: 10.1007/s11934-013-0310-4.
Percutaneous nephrolithotomy (PCNL) is the gold standard for the treatment of large renal calculi. Recently, modifications to the standard PCNL with nephrostomy tube placement have evolved, most notably the introduction of tubeless PCNL. Tubeless PCNL appears to decrease postoperative discomfort and shorten hospital stays, without increasing complication rates in the appropriately selected patient population. Urologists have attempted to expand the role of tubeless PCNL in more complex clinical scenarios, including pediatric and geriatric patients, and in stones complicated by multiple access tracts, renal anomalies or previous renal surgery. In an attempt to further improve outcomes following tubeless PCNL, adjunct interventions such as the use of hemostatic agents along the percutaneous access tract and local tract anesthetic have also been evaluated. We report the most recent published data over the past year, reviewing the employment and efficacy of tubeless PCNL, and discuss the selection of appropriate patients for this modified procedure.
经皮肾镜碎石术(PCNL)是治疗大肾结石的金标准。最近,经皮肾镜碎石术联合肾造瘘管放置的标准术式发生了变化,最显著的是无管化经皮肾镜碎石术的出现。无管化经皮肾镜碎石术似乎可以减轻术后不适并缩短住院时间,而在适当选择的患者人群中不会增加并发症发生率。泌尿科医生试图将无管化经皮肾镜碎石术扩展到更复杂的临床情况,包括儿科和老年患者,以及存在多通道、肾脏异常或既往肾脏手术的结石的患者。为了进一步改善无管化经皮肾镜碎石术后的效果,还评估了辅助干预措施,如在经皮通道沿线使用止血剂和局部通道麻醉。我们报告了过去一年中最新的已发表数据,回顾了无管化经皮肾镜碎石术的应用和疗效,并讨论了为该改良手术选择合适患者的问题。